Related Experiment Video
Updated: Aug 13, 2026
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
[Bioethics in severely neurologically disturbed children]
1Kyoto University, Kyoto.
Insights
Physicians must obtain informed consent from guardians for severely neurologically impaired children, providing comprehensive information about treatments and risks. This ensures ethical care for conditions like spina bifida and neuroblastoma.
Area of Science:
- Pediatric Neurology
- Bioethics
- Medical Law
Context:
- Severely neurologically disturbed children often lack decision-making capacity.
- Guardians must provide proxy consent for medical treatments.
- Physicians have a duty to disclose comprehensive information to guardians.
Purpose:
- To outline bioethical considerations in treating neurologically impaired children.
- To emphasize the importance of informed consent via guardians.
- To detail the physician's obligation in information disclosure.
Summary:
- Informed consent is crucial for treating children with severe neurological impairments.
- Guardians provide proxy consent after physicians detail conditions, procedures, and risks.
- Bioethical principles apply to conditions including neural tube defects, metabolic disorders, tumors, epilepsy, and prenatal diagnoses.
Impact:
- Ensures ethical medical decision-making for vulnerable pediatric populations.
- Upholds patient rights through guardian advocacy.
- Provides a framework for managing complex pediatric neurological cases ethically.
Abstract:
Informed consent is essential for bioethical considerations when physicians treat severely neurologically disturbed children. Because these patients are immature for their decision-making, proxy consent must be given to their physicians by their guardian to accept within agreeable limits of treatments and care for them. Prior to obtaining the consent, given by their guardians, physicians are obliged to provide their guardians with necessary informations regarding patients' physical conditions and details of procedures for proposed treatments, as well as possible risks involved in these treatments and care to be provided. Clinical applications of bioethical considerations are given to the patients with following diseases: spina bifida cystica and other neural tube defects, congenital metabolic disorders such as cretinism and phenylketonuria, malignant tumors such as neuroblastoma and retinoblastoma, and intractable epilepsy. Bioethical considerations are also given to prenatal diagnosis for early discovery, diagnosis and possible treatments of severely neurologically disturbed fetuses.
